Menü
You have to log in or sign up before you can proceed.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages
MEDICREA® Announces FDA Clearance of the World’s First Patient-Matched Spinal Interbody Cages


MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling

NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019

Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation
Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation


Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims

Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors
Dr. Scott Gottlieb, former US FDA Commissioner, joins Illumina’s Board of Directors


Illumina, Inc. (NASDAQ: ILMN) announced today that Scott Gottlieb, M.D. has joined the company’s Board of Directors, effective February 4, 2020. Dr. Gottlieb is currently a special partner at the

More Than 200 Companies Select Veeva Vault RIM Applications to Streamline Regulatory Operations
More Than 200 Companies Select Veeva Vault RIM Applications to Streamline Regulatory Operations


Veeva Systems (NYSE:VEEV) today announced an increasing number of life sciences companies are adopting applications in the Veeva Vault RIM Suite to streamline regulatory information management

Problem Zivilisationskrankheiten? Eher nicht für Aktionäre von Edwards Lifesciences...
Problem Zivilisationskrankheiten? Eher nicht für Aktionäre von Edwards Lifesciences...
Die Menschen werden immer älter, obwohl sie sich seltener bewegen und die Kalorienzufuhr ständig steigt. Kein Wunder, dass Erkrankungen des Herz-Kreislauf-Systems zu den häufigsten Todesursachen
Premier Inc. to Acquire Acurity and Nexera Businesses from the Greater New York Hospital Association
Premier Inc. to Acquire Acurity and Nexera Businesses from the Greater New York Hospital Association


Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that it has entered into a definitive agreement to acquire substantially all the assets and certain

Premier Inc. Reports Fiscal 2020 Second-Quarter Results
Premier Inc. Reports Fiscal 2020 Second-Quarter Results


Premier Inc. (NASDAQ: PINC) today reported financial results for the fiscal 2020 second quarter ended Dec. 31, 2019.



All results presented in this press release reflect continuing operations

Veeva to Release Fiscal 2020 Fourth Quarter and Full Year Results on March 3, 2020
Veeva to Release Fiscal 2020 Fourth Quarter and Full Year Results on March 3, 2020


Veeva Systems (NYSE:VEEV) will announce financial results for its fourth quarter and full fiscal year which ended January 31, 2020 after market close on March 3, 2020. Veeva will host a conference

MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment
MEDICREA®’s UNiD® ASI Technology Hits 5,000th Patient-Specific Spine Surgery Milestone With Strong Penetration of the Degenerative and Minimally Invasive Market Segment


MEDICREA® (Euronext Growth Paris : FR0004178572 – ALMED, PEA-PME eligible and OTCQX : MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling

Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial
Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial


Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of

Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics
Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics


Agilent Technologies Inc. (NYSE: A) today announced that it is joining forces with the Indian Institute of Technology Delhi (IIT Delhi) to promote biopharmaceutical research.



Agilent and IIT

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019


Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019.



Fourth quarter 2019 results:




  • Revenue of $953 million, a 10% increase compared

Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call
Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call


Agilent Technologies, Inc. (NYSE: A) will release first-quarter fiscal year 2020 financial results after the stock market closes on Feb. 18. The company will also host a live webcast of its

Quidel to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on February 12th, 2020
Quidel to Hold Fourth Quarter and Full Year 2019 Financial Results Conference Call on February 12th, 2020


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fourth quarter and full year 2019

LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2019 Results
LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2019 Results


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its fourth quarter and full-year 2019 results on Wednesday, Feb. 26

CommonSpirit Health Chooses Premier Inc. to Clinically Integrate its Newly Merged Supply Chain
CommonSpirit Health Chooses Premier Inc. to Clinically Integrate its Newly Merged Supply Chain


CommonSpirit Health will be partnering with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, to achieve operational excellence as it undergoes the complex integration of its

Agilent Introduces New Cutting-Edge SureSelect DNA Kit
Agilent Introduces New Cutting-Edge SureSelect DNA Kit


Agilent Technologies Inc. (NYSE: A) today introduced a new product designed to address key challenges that laboratories encounter when preparing DNA sequencing libraries for their research. The new

EOS imaging: Information Relating to the Total Number of Share Capital and Voting Rights
EOS imaging: Information Relating to the Total Number of Share Capital and Voting Rights


Regulatory News:



EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and

Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination
Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination


Regulatory News:



Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (pCLE/nCLE)

Humana Foundation Investing $7.6 Million in Eight Communities to Address Social Determinants of Health
Humana Foundation Investing $7.6 Million in Eight Communities to Address Social Determinants of Health


The Humana Foundation, philanthropic arm of Humana Inc. (NYSE: HUM) for the past 38 years, is investing $7.6 million in eight communities across the southeastern United States to address social

Lantheus Holdings Announces Senior Leadership Appointment
Lantheus Holdings Announces Senior Leadership Appointment


Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of innovative

Agilent Announces CrossLab Group Leadership Transition
Agilent Announces CrossLab Group Leadership Transition


Agilent Technologies Inc. (NYSE: A) today announced that Mark Doak, Agilent senior vice president and president of the Agilent CrossLab Group, has decided to retire on May 1, 2020. The company has

Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+Nephew PICO◊ sNPWT kanisterlose Unterdruck-Wundtherapie herkömmlicher tNPWT bei der Reduzierung von Wundfläche, -tiefe und -volumen bei DFU und UCV überlegen ist
Eine neu veröffentlichte multizentrische RCT zeigt, dass Smith+Nephew PICO◊ sNPWT kanisterlose Unterdruck-Wundtherapie herkömmlicher tNPWT bei der Reduzierung von Wundfläche, -tiefe und -volumen bei DFU und UCV überlegen ist


Smith+Nephew (LSE:SN, NYSE:SNN), das globale Medizintechnikunternehmen, freut sich, die Veröffentlichung von Ergebnissen aus einer neuen randomisierten kontrollierten klinischen Studie (RCT)

Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor
Texas Senior Games Opens Registration for 2020 Games, Announces Humana as Top Sponsor


Registration for the 2020 Texas Senior Games, the multi-sport competition for seniors that will be held March 26 through April 5, 2020, in San Antonio, is now open. For the first time, leading